publicationMetadata:
  pmid: "35648241"
  title: "Dose-dependent seizure control with MEK inhibitor therapy for progressive glioma in a child with neurofibromatosis type 1."
  queryType: "unknown"  # Not specified in input
  publicationType: "Clinical Study"
  publicationTypeConfidence: 0.95
  hasMethodsSection: No
  likelyContainsTools: Yes
  expectedToolTypes: |
    Clinical Study (case report) → clinical assessment tools, diagnostic tools, therapeutic agents
    
    This case report describes comprehensive clinical evaluation including:
    - Neurological assessments (EEG, neurologic examination)
    - Imaging studies (MRI, echocardiogram) 
    - Seizure monitoring and quantification
    - Cardiac function assessment
    - Academic performance evaluation
    
    While lacking traditional lab research tools, clinical case reports contain validated clinical
    assessment instruments and diagnostic procedures that qualify as research tools.
  overallAssessment: |
    This clinical case report documents detailed patient assessment and treatment monitoring over time.
    Clinical assessment tools are expected including EEG monitoring, neurological examinations, 
    imaging protocols, and seizure frequency tracking methods. The publication describes systematic
    clinical evaluation that would utilize validated assessment instruments and diagnostic procedures.

toolValidations: []  # No tools were mined to validate

potentiallyMissedTools:
  - toolName: "EEG"
    toolType: "clinical_assessment_tool"
    foundIn: "results"
    contextSnippet: "Routine awake EEG revealed focal epileptiform discharges...A 24-h EEG captured three electroclinical seizures...A recent 24-h EEG captured no electrographic or clinical seizures"
    whyMissed: "EEG is a standard clinical assessment tool for epilepsy evaluation but may not have been recognized as a research tool"
    confidence: 0.9
    shouldBeAdded: Yes

  - toolName: "24-hour EEG monitoring"
    toolType: "clinical_assessment_tool"
    foundIn: "results"
    contextSnippet: "A 24-h EEG captured three electroclinical seizures that lateralized to the right hemisphere but were poorly localized"
    whyMissed: "Extended EEG monitoring is a specialized clinical assessment tool for seizure characterization"
    confidence: 0.85
    shouldBeAdded: Yes

  - toolName: "Brain MRI"
    toolType: "clinical_assessment_tool"
    foundIn: "results"
    contextSnippet: "MRI of the brain revealed bilateral OPG with extension into the hypothalamus...Repeat brain MRI revealed slow progression of his glioma"
    whyMissed: "MRI is a clinical imaging assessment tool used for tumor monitoring and treatment response evaluation"
    confidence: 0.8
    shouldBeAdded: Yes

  - toolName: "Neurological examination"
    toolType: "clinical_assessment_tool"
    foundIn: "results"
    contextSnippet: "Physical examination was notable for café-au-lait macules, axillary freckling, and left-sided facial weakness...Examination was notable for dysarthria, left lower facial weakness"
    whyMissed: "Standardized neurological examination is a clinical assessment tool for evaluating neurological function"
    confidence: 0.75
    shouldBeAdded: Yes

  - toolName: "Echocardiogram"
    toolType: "clinical_assessment_tool"
    foundIn: "results"
    contextSnippet: "asymptomatic decline in left ventricular ejection fraction, 63% to 47%...upon subsequent normalization of echocardiogram findings"
    whyMissed: "Echocardiogram is a clinical assessment tool for cardiac function monitoring during treatment"
    confidence: 0.8
    shouldBeAdded: Yes

  - toolName: "Seizure frequency tracking"
    toolType: "clinical_assessment_tool"
    foundIn: "results"
    contextSnippet: "seizures occurred in clusters every 5–6 days, with seizure frequency ranging between 1 and 10 seizures per day...significantly decreased seizure frequency"
    whyMissed: "Systematic seizure frequency monitoring is a clinical outcome assessment tool"
    confidence: 0.7
    shouldBeAdded: Maybe

suggestedPatterns:
  - patternType: "term"
    pattern: "EEG|electroencephalogram|electroencephalography"
    toolType: "clinical_assessment_tool"
    examples: ["Routine awake EEG revealed", "A 24-h EEG captured"]
    reasoning: "EEG is a standard clinical assessment tool for neurological evaluation that should be consistently captured"

  - patternType: "term"
    pattern: "MRI|magnetic resonance imaging"
    toolType: "clinical_assessment_tool"
    examples: ["MRI of the brain revealed", "Repeat brain MRI revealed"]
    reasoning: "MRI is a clinical imaging assessment tool used for diagnosis and treatment monitoring"

  - patternType: "term"
    pattern: "echocardiogram|ECHO|cardiac ultrasound"
    toolType: "clinical_assessment_tool"
    examples: ["normalization of echocardiogram findings"]
    reasoning: "Echocardiogram is a clinical assessment tool for cardiac function evaluation"

  - patternType: "context_phrase"
    pattern: "neurological examination|neurologic examination|physical examination"
    toolType: "clinical_assessment_tool"
    examples: ["Physical examination was notable for", "Examination was notable for"]
    reasoning: "Standardized clinical examinations are assessment tools that should be captured"

  - patternType: "context_phrase"
    pattern: "seizure frequency|seizure monitoring|seizure tracking"
    toolType: "clinical_assessment_tool"
    examples: ["seizure frequency ranging between", "decreased seizure frequency"]
    reasoning: "Systematic seizure assessment is a clinical outcome measurement tool"

observations:
  - resourceName: "EEG"
    resourceType: "Clinical Assessment Tool"
    observationType: "Nervous System"
    observationTypeOntologyId: "MP:0003631"
    details: |
      Initial routine awake EEG revealed focal epileptiform discharges and prominent localized 
      slowing in the right temporal region. 24-hour EEG monitoring captured three electroclinical 
      seizures that lateralized to the right hemisphere but were poorly localized. After treatment 
      with full-dose selumetinib, a recent 24-hour EEG captured no electrographic or clinical seizures, 
      demonstrating complete seizure control.
    foundIn: "results"
    contextSnippet: "Routine awake EEG revealed focal epileptiform discharges and prominent localized slowing in the right temporal region...A recent 24-h EEG captured no electrographic or clinical seizures"
    confidence: 0.95
    doi: "10.1007/s00381-022-05571-y"

  - resourceName: "Brain MRI"
    resourceType: "Clinical Assessment Tool"
    observationType: "Tumor Growth"
    observationTypeOntologyId: "MP:0002006"
    details: |
      Initial brain MRI revealed bilateral optic pathway glioma with extension into hypothalamus, 
      basal ganglia, and subcortical white matter, with mass effect on right insular cortex. 
      Follow-up MRI showed slow progression over 2 years with new enhancement in right frontal lobe. 
      After selumetinib treatment, MRI showed stable mass size but interval reduction in enhancement 
      of the right frontal lesion, suggestive of treatment response.
    foundIn: "results"
    contextSnippet: "MRI of the brain revealed bilateral OPG with extension into the hypothalamus, basal ganglia, and subcortical white matter...Repeat brain MRI showed stable mass size but interval reduction in enhancement"
    confidence: 0.9
    doi: "10.1007/s00381-022-05571-y"

  - resourceName: "Neurological examination"
    resourceType: "Clinical Assessment Tool"
    observationType: "Nervous System"
    observationTypeOntologyId: "MP:0003631"
    details: |
      Initial examination showed café-au-lait macules, axillary freckling, and left-sided facial weakness. 
      At age 8, examination revealed dysarthria, left lower facial weakness, left upper extremity weakness, 
      and mild circumduction of left lower extremity while walking. After full-dose selumetinib treatment, 
      improvements in alertness, left-sided weakness, and gait were noted on neurologic examination.
    foundIn: "results"
    contextSnippet: "Physical examination was notable for café-au-lait macules, axillary freckling, and left-sided facial weakness...Improvements in alertness, left-sided weakness, and gait were also noted on neurologic examination"
    confidence: 0.85
    doi: "10.1007/s00381-022-05571-y"

  - resourceName: "Echocardiogram"
    resourceType: "Clinical Assessment Tool"
    observationType: "Cardiovascular System"
    observationTypeOntologyId: "MP:0005385"
    details: |
      Routine cardiac monitoring revealed asymptomatic decline in left ventricular ejection fraction 
      from 63% to 47% after 12 weeks of selumetinib treatment, indicating cardiac toxicity. 
      Echocardiogram findings subsequently normalized after drug hold, allowing for treatment resumption 
      with cardioprotective measures.
    foundIn: "results"
    contextSnippet: "he displayed evidence of cardiac toxicity on routine evaluation at this time (asymptomatic decline in left ventricular ejection fraction, 63% to 47%)...upon subsequent normalization of echocardiogram findings"
    confidence: 0.9
    doi: "10.1007/s00381-022-05571-y"

  - resourceName: "Seizure frequency tracking"
    resourceType: "Clinical Assessment Tool"
    observationType: "Nervous System"
    observationTypeOntologyId: "MP:0003631"
    details: |
      Baseline seizure pattern showed clusters every 5-6 days, with frequency ranging between 1-10 
      seizures per day for 3-5 days during clusters despite multiple antiepileptic drugs. After 12 weeks 
      of full-dose selumetinib, significantly decreased seizure frequency was observed. Seizure frequency 
      increased to pre-treatment baseline on 50% dose reduction, then improved dramatically with return 
      to full dosing. Patient currently remains seizure-free on full-dose selumetinib.
    foundIn: "results"
    contextSnippet: "seizures occurred in clusters every 5–6 days, with seizure frequency ranging between 1 and 10 seizures per day...significantly decreased seizure frequency...Currently, the patient remains seizure-free"
    confidence: 0.8
    doi: "10.1007/s00381-022-05571-y"

summary:
  totalToolsMined: 0
  toolsAccepted: 0
  toolsRejected: 0
  toolsUncertain: 0
  potentiallyMissedCount: 6
  newPatternsCount: 5
  observationsExtracted: 5
  observationsByType:
    Nervous System: 3
    Tumor Growth: 1
    Cardiovascular System: 1
  majorIssuesFound: |
    - Mining system failed to identify any clinical assessment tools despite extensive clinical evaluation
    - Case report format may not be recognized as containing research tools
    - Clinical assessment tools (EEG, MRI, neurological examination) were not captured
    - Systematic clinical monitoring and outcome assessment tools were missed
    - Publication lacks traditional Methods section but contains detailed clinical methodology
  recommendations: |
    This clinical case report contains multiple valid clinical assessment tools that were completely 
    missed by the mining system. All 6 potentially missed tools should be added as they represent 
    standard clinical assessment instruments used for patient evaluation and treatment monitoring.
    
    The mining patterns need significant enhancement to capture clinical assessment tools in case 
    reports and clinical studies. The suggested patterns would improve detection of EEG, imaging 
    studies, clinical examinations, and outcome monitoring tools.
    
    Five high-quality scientific observations were extracted showing treatment response across 
    multiple clinical domains (neurological, cardiac, tumor response). This demonstrates the value 
    of clinical case reports for documenting tool performance and patient outcomes.
    
    Future mining should recognize that clinical studies without traditional Methods sections can 
    still contain valuable research tools and systematic clinical assessments.
